Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Immuno-oncology Pharma
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
29.42M 50.08%
Immuno-oncology Pharma
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
17.94M 30.53%
Immuno-oncology Pharma
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
9.83M 16.74%
Immuno-oncology Pharma
Contract Research for Drug Manufacturers; government-sponsored
These companies do contract services for biotech and pharmaceutical companies.
1.56M 2.65%
keyboard_arrow_right keyboard_arrow_down
Immuno-oncology Pharma
Pharmaceutical Patent Licensing
29.42M 50.08%
keyboard_arrow_right
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
keyboard_arrow_right keyboard_arrow_down
Immuno-oncology Pharma
Branded Pharmaceuticals
17.94M 30.53%
keyboard_arrow_right
These companies research, develop, and manufacture patented drugs.
keyboard_arrow_right keyboard_arrow_down
Immuno-oncology Pharma
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
9.83M 16.74%
keyboard_arrow_right
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
keyboard_arrow_right keyboard_arrow_down
Immuno-oncology Pharma
Contract Research for Drug Manufacturers; government-sponsored
1.56M 2.65%
keyboard_arrow_right
These companies do contract services for biotech and pharmaceutical companies.